Ling Zeng
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- Immune cells in cancer
- interferon and immune responses
Papers in
-
- Inflammasome and immune disorders 11
- Epigenetics and DNA Methylation 7
- Immunology 32
- Immune Response and Inflammation 21
- Immune cells in cancer 7
- Co-authors
- Jianxin Jiang (45 shared papers)Rui Kang (14 shared papers)Daolin Tang (14 shared papers)Timothy R. Billiar (11 shared papers)Haichao Wang (11 shared papers)Lizhi Cao (6 shared papers)Shan Zhu (6 shared papers)Guido Kroemer (5 shared papers)
- Journals
- Critical Care (9 papers)Medicine (6 papers)Frontiers in Genetics (4 papers)International Journal of Molecular Sciences (4 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ling Zeng
139 papers receiving 4.6k citations
Ling Zeng's Hit Papers
Peers
Comparison fields: 5 of 142
- Immunology 1.1k
- Critical Care and Intensive Care Medicine 153
- Cancer Research 472
- Molecular Biology 1.9k
- Epidemiology 811
Countries citing papers authored by Ling Zeng
This map shows the geographic impact of Ling Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zeng more than expected).
Fields of papers citing papers by Ling Zeng
This network shows the impact of papers produced by Ling Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zeng. The network helps show where Ling Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis Hit paper breakdown → | 2018 | 505 |
| 2 | PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation Hit paper breakdown → | 2016 | 449 |
| 3 | Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options Hit paper breakdown → | 2022 | 413 |
| 4 | 2019 | 230 | |
| 5 | 2020 | 168 | |
| 6 | 2018 | 130 | |
| 7 | 2019 | 118 | |
| 8 | 2017 | 105 | |
| 9 | 2020 | 102 | |
| 10 | 2021 | 100 | |
| 11 | 2015 | 92 | |
| 12 | 2021 | 90 | |
| 13 | 2016 | 88 | |
| 14 | 2021 | 78 | |
| 15 | 2009 | 75 | |
| 16 | 2020 | 67 | |
| 17 | 2021 | 64 | |
| 18 | 2022 | 63 | |
| 19 | 2018 | 59 | |
| 20 | 2012 | 55 |
About Ling Zeng
Ling Zeng is a scholar working on Molecular Biology, Immunology, Epidemiology, Pulmonary and Respiratory Medicine and Oncology, having authored 151 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (21 papers), Sepsis Diagnosis and Treatment (13 papers), Inflammasome and immune disorders (11 papers), Epigenetics and DNA Methylation (7 papers), Immune cells in cancer (7 papers), Autophagy in Disease and Therapy (6 papers), Heavy Metal Exposure and Toxicity (6 papers) and Neonatal Respiratory Health Research (5 papers). The work is most often cited by research in Immunology (1.1k citations), Critical Care and Intensive Care Medicine (153 citations), Cancer Research (472 citations), Molecular Biology (1.9k citations) and Epidemiology (811 citations). Ling Zeng has collaborated with scholars based in China, United States and France. Frequent co-authors include Jianxin Jiang, Rui Kang, Daolin Tang, Timothy R. Billiar, Haichao Wang, Lizhi Cao, Shan Zhu, Guido Kroemer, Anqiang Zhang and Min Xie. Their work appears in journals such as Critical Care, Medicine, Frontiers in Genetics, International Journal of Molecular Sciences and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.